Sandra Levy
ARTICLES BY THIS AUTHOR
- 3/13/2022
Lupin gets FDA blessing for generic Vigabatrin
Vigabatrin for Oral Solution had a market value of roughly $275 million, according to December 2021 IQVIA data. - 3/13/2022
Walgreens SVP, general counsel to depart
Elena Kraus is leaving Walgreens, where she served for six years as senior vice president and general counsel, to join Whataburger as executive vice president and chief legal officer. - 3/13/2022
NACDS poll shows support for extending policies offering access to essential services from pharmacies
The services, made possible under the Public Readiness and Emergency Preparedness Act, relate to COVID-19 tests, vaccinations and therapeutics, childhood vaccinations, and flu vaccinations. - 3/10/2022
AAM launches Markup Madness campaign
The Markup Madness campaign is aimed at highlighting the role that the big men in the middle play in running up the score on patients, the organization said. - 3/10/2022
Walmart’s Baytown campus adds distribution center
Walmart shared that the expansion will create an additional 300 permanent supply chain jobs surrounding the Houston area. - 3/10/2022
Teva debuts Revlimid generic
Teva’s lenalidomide capsules are used in adults for the treatment of multiple myeloma in combination with the medicine dexamethasone. - 3/9/2022
Par debuts Vasostrict
Endo’s Par Sterile Products business is offering Vasostrict, vasopressin injection, in ready-to-use 100 ml premix bottles. - 3/9/2022
CVS Health makes changes to board of directors
Tony White and David Dorman are retiring from the board, and Roger Farah has been named independent chair. - 3/9/2022
Walmart to offer mental health platform for caregivers, vitamin subscription plan
The BetterUp for Caregivers platform provides customized tools and community support, and Easy Vitamin Plan is a personalized vitamin subscription service. - 3/9/2022
Pharmacy orgs ask Biden administration to remove prescribing limits on COVID-19 treatments
Fourteen pharmacy organizations are urging for modification to EUAs for oral antivirals in order to achieve the potential of the "test to treat" initiative.
